Effects of Finerenone on Renal Hemodynamics and Oxidative Stress
This research is investigating a medicine called Kerendia (finerenone) for people who have type 2 diabetes. The main goal is to understand if Kerendia can improve how well your kidneys work by lessening a type of stress, called 'oxidative stress', on the blood vessels within your kidneys. Researchers will compare the effects of Kerendia to a placebo, which is a tablet that looks the same but contains no active medicine. They will measure changes in how blood flows through the kidneys after giving a vitamin C infusion, as a way to see if the medicine is making a difference. This is a Phase 3 study, meaning it's a further step to confirm if the treatment is effective and safe.
At a glance
What is this study about?
This study is focused on people who have type 2 diabetes. It's looking at how a specific medicine, called finerenone (you might know it as Kerendia), affects the kidneys. Kidneys are super important organs that filter waste from your blood, and sometimes, in people with diabetes, they can become stressed and not work as well. This 'stress' is sometimes called oxidative stress, and it can affect the tiny blood vessels inside your kidneys.
The main idea behind this research is to see if finerenone can help reduce this stress and improve how blood flows through your kidneys. The study will compare two groups of people: one group will receive finerenone, and the other will receive a 'placebo'. A placebo is a tablet that looks exactly like the medicine but doesn't contain any active drug. This helps the researchers know for sure if any changes seen are due to the medicine itself and not just other factors.
To figure out if the medicine is working, the researchers will carefully measure how blood flows into your kidneys. They will do this by giving you a special vitamin C solution. This isn't just about vitamins; it's a specific way to check kidney blood flow. By comparing the results from the finerenone group to the placebo group, they hope to understand if finerenone can indeed make a positive difference in protecting the kidneys of people with type 2 diabetes.
Key takeaways
- This study is for adults with type 2 diabetes.
- It tests a medicine called Kerendia (finerenone) for kidney protection.
- Compares Kerendia to a placebo (dummy pill).
- Involves regular clinic visits and special kidney function tests.
- Aims to understand how Kerendia affects kidney blood vessels and stress.
- Participation is voluntary, and you can withdraw at any time.
Who may be eligible?
This study is looking for adults who have type 2 diabetes. To join, you must be 18 years old or older. There is no upper age limit, meaning older adults with type 2 diabetes can also take part.
Both men and women are welcome to participate in this research. The study needs a diverse group of people to make sure the results apply to many different individuals with type 2 diabetes.
Beyond basic age and sex, there will be other health requirements the research team will check to make sure the study is safe and appropriate for you. For example, they will need to check your general health, how well your kidneys are currently working, and any other medications you might be taking. These detailed checks help ensure the study is suitable for everyone involved.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of type 2 diabetes?
- Are you comfortable attending regular clinic appointments?
- Are you generally in good health other than your diabetes?
- Are you able to take tablets by mouth?
- Are you willing to have blood samples and other tests taken?
What does participation involve?
If you decide to take part in this study, you will be given study tablets to take by mouth – either doses of Kerendia (finerenone) or a placebo (a dummy tablet). You won't know which one you are taking, and neither will the study team, to keep the results fair. During the study, you will have several appointments at the clinic. These visits will involve various tests and assessments, such as blood and urine samples, and checks of your blood pressure and weight.
A key part of the study will involve specific tests to measure how blood flows through your kidneys. This may include receiving an infusion of a special solution with vitamin C. The exact number of visits, tests, and the total length of time you'll be involved in the study will be fully explained by the research team if you are interested. You will also have follow-up appointments to monitor your health and any effects of the study medication.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is the main purpose of this study?
The study aims to see if a medicine called Kerendia (finerenone) can help reduce stress on kidney blood vessels and improve kidney function in people with type 2 diabetes.
What is a 'placebo'?
A placebo is a tablet that looks just like the study medicine but doesn't contain any active drug. It's used to compare against the real medicine to see if the drug is truly working.
Will I know if I'm getting the real medicine or the placebo?
No, neither you nor the study team will know during the study. This helps make the results fairer and more reliable.
What kind of tests will I have?
You will have regular check-ups, blood and urine tests, and special tests to measure blood flow in your kidneys using things like a vitamin C infusion.
Can I leave the study if I change my mind?
Yes, you have the right to leave the study at any point, for any reason, without affecting your medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.